Pillstats
Tablet, Film Coated

Levetiracetam

Levetiracetam

3 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US8 NDCs
3 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
RxCUI (US)114477
US makers3 labelers
Packages10
DEA / ScheduleNone

US acquisition costNADAC · per unit

Average across 2 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$0.022$0.045$0.067$0.090Dec 2025Apr 2026Jul 2026
$0.075
Latest avg · Jul 22, 2026
-2%
Since Dec 17, 2025
3
Active US suppliers
70%
Top-2 supplier share*

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

27K53K80K107K2025 Q12025 Q22025 Q32025 Q42026 Q1
77K
Rx · 2026 Q1
7.8M
Units dispensed
-17%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it3 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
UCB Pharma S.A.unknown4SUPPLYING
Aurobindo Pharma Limitedunknown3SUPPLYING
UCB Farchim S.A.unknown3SUPPLYING

Regulatory & supply events

No recalls, shortages, or registration changes on record for this drug concept.